New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
A cellular model system for drug development in fatty liver disease

A cellular model system for drug development in fatty liver disease

by Eva Maria Wellnitz, Universitätsmedizin MannheimThe model system: Healthy liver cells of different origin are cultured in a 3D collagen sandwich system and development towards fatty liver cells is
Hepatobiliary&Pancreas Surgery October 04,2024
A cellular model system for drug development in fatty liver disease

A cellular model system for drug development in fatty liver disease

by Eva Maria Wellnitz, Universitätsmedizin MannheimThe model system: Healthy liver cells of different origin are cultured in a 3D collagen sandwich system and development towards fatty liver cells is
Hepatobiliary&Pancreas Surgery October 04,2024
Experimental blood test predicts risk for developing COPD, other severe respiratory diseases

Experimental blood test predicts risk for developing COPD, other severe respiratory diseases

byNIH/National Heart, Lung and Blood InstituteCredit: Karolina Grabowska from PexelsA research team has created a preclinical blood test to identify adults most likely to develop severe respirat
Emergency Medicine & Critical Care October 04,2024
Experimental blood test predicts risk for developing COPD, other severe respiratory diseases

Experimental blood test predicts risk for developing COPD, other severe respiratory diseases

byNIH/National Heart, Lung and Blood InstituteCredit: Karolina Grabowska from PexelsA research team has created a preclinical blood test to identify adults most likely to develop severe respirat
Emergency Medicine & Critical Care October 04,2024
Coordinated care important for children with Down syndrome and congenital heart disease, say researchers

Coordinated care important for children with Down syndrome and congenital heart disease, say researchers

byAmerican Heart AssociationA family‐centered, developmentally supportive care model for children with trisomy 21 and congenital heart disease from birth through adolescence. Credit:Journa
Pediatrics October 04,2024
Coordinated care important for children with Down syndrome and congenital heart disease, say researchers

Coordinated care important for children with Down syndrome and congenital heart disease, say researchers

byAmerican Heart AssociationA family‐centered, developmentally supportive care model for children with trisomy 21 and congenital heart disease from birth through adolescence. Credit:Journa
Pediatrics October 04,2024
Cross-disciplinary research makes strides in hepatitis C vaccine development

Cross-disciplinary research makes strides in hepatitis C vaccine development

byUniversity of CopenhagenE1–E2 interaction in the membrane. Credit:Nature(2024). DOI: 10.1038/s41586-024-07783-5Around 58 million people suffer from chronic inflammation caused by t
Hepatobiliary&Pancreas Surgery October 04,2024
Cross-disciplinary research makes strides in hepatitis C vaccine development

Cross-disciplinary research makes strides in hepatitis C vaccine development

byUniversity of CopenhagenE1–E2 interaction in the membrane. Credit:Nature(2024). DOI: 10.1038/s41586-024-07783-5Around 58 million people suffer from chronic inflammation caused by t
Hepatobiliary&Pancreas Surgery October 04,2024
A new mechanism of early-onset atherosclerosis in a premature aging syndrome

A new mechanism of early-onset atherosclerosis in a premature aging syndrome

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Activation of EndMT in atherosclerotic plaques in mice with progeria The left panel shows an atherosclerotic plaque in an arte
Cardiovascular Diseases October 04,2024
A new mechanism of early-onset atherosclerosis in a premature aging syndrome

A new mechanism of early-onset atherosclerosis in a premature aging syndrome

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Activation of EndMT in atherosclerotic plaques in mice with progeria The left panel shows an atherosclerotic plaque in an arte
Cardiovascular Diseases October 04,2024
Wearable lung patch uses deep learning to detect asthma and COPD

Wearable lung patch uses deep learning to detect asthma and COPD

by Christine Lehmann,National Institutes of HealthThe microchip sensor is slightly larger than a penny. Credit: StethX and the Georgia Institute of Technology. Wheezing, a high-pitched whi
Pulmonology October 03,2024
Wearable lung patch uses deep learning to detect asthma and COPD

Wearable lung patch uses deep learning to detect asthma and COPD

by Christine Lehmann,National Institutes of HealthThe microchip sensor is slightly larger than a penny. Credit: StethX and the Georgia Institute of Technology. Wheezing, a high-pitched whi
Pulmonology October 03,2024
Discovery could help treat fatal, drug-resistant pneumonia and sepsis

Discovery could help treat fatal, drug-resistant pneumonia and sepsis

by Marcia Locke,Kansas State UniversityNociceptor neurons suppress host protection against CRKP pneumonia and pneumonic sepsis. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adl
Pulmonology October 03,2024
Discovery could help treat fatal, drug-resistant pneumonia and sepsis

Discovery could help treat fatal, drug-resistant pneumonia and sepsis

by Marcia Locke,Kansas State UniversityNociceptor neurons suppress host protection against CRKP pneumonia and pneumonic sepsis. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adl
Pulmonology October 03,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com